Skip to main content
OpenTrials

Clinical trial condition

Angioimmunoblastic T-cell Lymphoma

Explore clinical trials studying Angioimmunoblastic T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

71 public trials 5 recruiting studies

Angioimmunoblastic T-cell Lymphoma trial results

Conditions
ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations
  • British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
Conditions
Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Miami, Florida, United States
  • Baltimore, Maryland, United States